Edinburgh, United Kingdom

Iomet Pharma Ltd.


USPTO Granted Patents = 10


Forward Citations = 16

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Alan Wise (9 out of 10 patents)

silverMedal Phillip Martin Cowley (9 out of 11 patents)

bronzeMedal Susan Davis (4 out of 7 patents)

4.  Michael Kiczun (4 out of 5 patents)

5.  Yongxin Han (3 out of 66 patents)

6.  Margaret Huggett (3 out of 3 patents)

7.  Hua Zhou (2 out of 896 patents)

8.  Meredeth Ann McGowan (2 out of 16 patents)

9.  Thomas James Brown (2 out of 3 patents)

10.  Qinglin Pu (1 out of 15 patents)

11.  Hongjun Zhang (1 out of 41 patents)

12.  Bill Hunter (1 out of 1 patent)

13.  Stuart McElroy (1 out of 1 patent)

14.  Kun Liu (1 out of 48 patents)

15.  Yongqi Deng (22 patents)


10 patents:

Company Overview
Iomet Pharma Ltd. is a biopharmaceutical company based in Edinburgh, specializing in the development of innovative therapies for cancer treatment. The organization focuses on advancing novel drug candidates that target specific cancer pathways, aiming to improve patient outcomes through precision medicine. With a commitment to research and development, Iomet Pharma leverages cutting-edge technology to explore new therapeutic options, contributing to the evolving landscape of oncology and personalized healthcare solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#16 in Edinburgh

#1,731 in United Kingdom

#56,047 in the World

Edinburgh, GB
Edinburgh, United Kingdom
Forward Citations = 16

14 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Iomet Pharma Ltd.. Retrieved from https://idiyas.com/company/iomet-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…